DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SD-0006
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SD-0006
×
Maximum Phase:
1
First Approval:
None
UNII:
C57VF8YO91
Molecule Type:
Small molecule
Molecular Formula:
C20H20ClN5O2
Molecular Weight:
397.87
AlogP:
2.89
PSA:
95.0
HBD:
2.0
HBA:
#RotB:
4.0
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MLN3126
1
Small molecule
Investigational
Unknown
Unknown
Unknown
C-C chemokine receptor type 9 antagonist
MLN3126
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAS190792
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
LAS190792
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETA ALETHINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BETA ALETHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DESMETRAMADOL
1
Small molecule
Investigational
Unknown
Unknown
Pain
Unknown
DESMETRAMADOL
×
Maximum Phase:
1
First Approval:
None
UNII:
2WA8F50C3F
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO2
Molecular Weight:
249.35
AlogP:
2.33
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AMG-548
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
AMG-548
×
Maximum Phase:
1
First Approval:
None
UNII:
PGR0H531I4
Molecule Type:
Small molecule
Molecular Formula:
C29H27N5O
Molecular Weight:
461.57
AlogP:
4.64
PSA:
85.83
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PERTECHNETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PERTECHNETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
HO4Tc
Molecular Weight:
163.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PHENANTHRENE
1
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder
Unknown
PHENANTHRENE
×
Maximum Phase:
1
First Approval:
None
UNII:
448J8E5BST
Molecule Type:
Small molecule
Molecular Formula:
C14H10
Molecular Weight:
178.23
AlogP:
3.99
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
AZD-7451
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Nerve growth factor receptor Trk-A inhibitor
AZD-7451
×
Maximum Phase:
1
First Approval:
None
UNII:
VNM956Y27V
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MUSCIMOL
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Parkinson Disease
Unknown
MUSCIMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
D5M179TY2E
Molecule Type:
Small molecule
Molecular Formula:
C4H6N2O2
Molecular Weight:
114.1
AlogP:
-0.16
PSA:
72.28
HBD:
2.0
HBA:
#RotB:
1.0
Source:
GS-6620
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
GS-6620
×
Maximum Phase:
1
First Approval:
None
UNII:
WD5DUG7X38
Molecule Type:
Small molecule
Molecular Formula:
C29H37N6O9P
Molecular Weight:
644.62
AlogP:
2.88
PSA:
209.62
HBD:
3.0
HBA:
#RotB:
12.0
Source:
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LANOPEPDEN MESYLATE
1
Small molecule
Investigational
Unknown
Unknown
Infections
Unknown
LANOPEPDEN MESYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
YW25HPP501
Molecule Type:
Small molecule
Molecular Formula:
C23H38FN7O7S
Molecular Weight:
575.66
AlogP:
0.93
PSA:
123.16
HBD:
3.0
HBA:
#RotB:
9.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
BRICICLIB SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
BRICICLIB SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
7C9N0VM8NR
Molecule Type:
Small molecule
Molecular Formula:
C19H21Na2O10PS
Molecular Weight:
518.39
AlogP:
2.78
PSA:
137.82
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TALADEGIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis
Smoothened homolog antagonist
TALADEGIB
×
Maximum Phase:
1
First Approval:
None
UNII:
QY8BWX1LJ5
Molecule Type:
Small molecule
Molecular Formula:
C26H24F4N6O
Molecular Weight:
512.51
AlogP:
4.93
PSA:
67.15
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ON123300
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ON123300
×
Maximum Phase:
1
First Approval:
None
UNII:
QJ8RO3296G
Molecule Type:
Small molecule
Molecular Formula:
C24H27N7O
Molecular Weight:
429.53
AlogP:
3.27
PSA:
90.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BI113823
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Bradykinin B1 receptor antagonist
BI113823
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RECILISIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase class I inhibitor
RECILISIB
×
Maximum Phase:
1
First Approval:
None
UNII:
F5V4K11SYV
Molecule Type:
Small molecule
Molecular Formula:
C16H13ClO4S
Molecular Weight:
336.8
AlogP:
3.62
PSA:
71.44
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-794833
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-794833
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LEVOSULPIRIDE
1
Small molecule
Investigational
Unknown
Unknown
Dyspepsia; Psychomotor Agitation; Psychotic Disorders
Dopamine D2 receptor antagonist
LEVOSULPIRIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
JTG7R315LK
Molecule Type:
Small molecule
Molecular Formula:
C15H23N3O4S
Molecular Weight:
341.43
AlogP:
0.56
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LY-3200882
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
LY-3200882
×
Maximum Phase:
1
First Approval:
None
UNII:
19HY34R6UN
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O3
Molecular Weight:
435.53
AlogP:
4.67
PSA:
94.32
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ZD-4190
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor 2 inhibitor
ZD-4190
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H17BrClFN6O2
Molecular Weight:
495.74
AlogP:
3.95
PSA:
86.98
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BMS-903452
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus
Unknown
BMS-903452
×
Maximum Phase:
1
First Approval:
None
UNII:
49731B9ULN
Molecule Type:
Small molecule
Molecular Formula:
C21H19Cl2FN4O4S
Molecular Weight:
513.38
AlogP:
3.52
PSA:
94.39
HBD:
0.0
HBA:
#RotB:
5.0
Source:
1
2
…
73
74
75
76
77
78
79
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA